14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
TEM vs DOCS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
DOCS Overall Winner
6-Pillar Tally: TEM 2 – 4 DOCS
Matrix Metrics: TEM 3 – 7 DOCS
As of Nov 17, 2026, Doximity, Inc. (DOCS) is the stronger overall head-to-head candidate over Tempus AI, Inc. (TEM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). TEM carries a Unified Composite Score of 43.5/100 (HOLD) at $63.08 (N/M Forward P/E, -18.5% operating margin), whereas DOCS carries 56.2/100 (HOLD) at $31.25 (20.2x Forward P/E, 27.1% operating margin).
Growth vs. Quality Trade-Off: DOCS earns the overall head-to-head edge with a stronger Unified Composite Score (56.2/100 HOLD vs. TEM 43.5/100 HOLD) and 0.68β · 42% Vol risk profile, whereas TEM leads top-line expansion (+23.1% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: TEM is currently in a Breakdown options structure phase (RSI 40.3); meanwhile DOCS trades in a Neutral technical trend (SURGE options phase, RSI 46.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Health Information Services value chain with $5.9B market capitalization and 27.1% operating margin.
OpEx & R&D Reinvestment59.7% of Rev ($395M)
90D Engineering Disclosures0 Published
Investor FAQ TEM vs DOCS Key Questions & Quantitative Answers
As of Nov 17, 2026, Doximity, Inc. (DOCS) is the stronger overall head-to-head candidate over Tempus AI, Inc. (TEM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). TEM carries a Unified Composite Score of 43.5/100 (HOLD) at $63.08 (N/M Forward P/E, -18.5% operating margin), whereas DOCS carries 56.2/100 (HOLD) at $31.25 (20.2x Forward P/E, 27.1% operating margin). Growth vs. Quality Trade-Off: DOCS earns the overall head-to-head edge with a stronger Unified Composite Score (56.2/100 HOLD vs. TEM 43.5/100 HOLD) and 0.68β · 42% Vol risk profile, whereas TEM leads top-line expansion (+23.1% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: TEM is currently in a Breakdown options structure phase (RSI 40.3); meanwhile DOCS trades in a Neutral technical trend (SURGE options phase, RSI 46.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
TEM leads the Growth & Scale pillar: TEM posts +23.1% YoY revenue growth and +0.0% YoY earnings growth on $1.51B TTM revenue (64.5% gross margin, -18.5% operating margin), compared with DOCS at +3.6% YoY revenue growth and -41.9% YoY earnings growth on $662M TTM revenue (86.8% gross margin, 27.1% operating margin). Across the 7-period historical trajectory (FY2020 to FY2026), TEM cumulative revenue shifted +296.9% while DOCS shifted +433.3%. In operating R&D and SG&A reinvestment, TEM deploys 83.0% of Rev ($1.25B) (0 90-day corporate R&D disclosures) versus 59.7% of Rev ($395M) (0 disclosures) for DOCS.
DOCS screens cheaper on headline valuation multiples. TEM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 9.2x EV/Revenue (-10.0% FCF margin), whereas DOCS trades at 20.2x Forward P/E, 46.3x Trailing P/E, 0.59x PEG, and 8.7x EV/Revenue (44.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TEM (-37.5% ROE) versus DOCS (13.8% ROE) capital efficiency.
In options market volatility and institutional positioning, TEM carries 99.3% implied volatility (44th %ile, Balanced (25th–60th %ile)), a 0.49x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.51β · 93% Vol realized risk). By comparison, DOCS carries 42.5% implied volatility (33rd %ile, Balanced (25th–60th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.68β · 42% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.